NCT00946101 - A Study to Evaluate the Safety of HIN1 Monovalent Vaccine (MEDI3414) in Children 2 to 17 Years of Age | Biotech Hunter

Enrollment

326

Participants

Timeline

Start Date

August 31, 2009

Primary Completion Date

September 30, 2009

Study Completion Date

March 31, 2010

Conditions

Influenza

Interventions

BIOLOGICAL

MEDI3414 [Influenza A(H1N1) live attenuated, intranasal]

0.5 mL: (intranasal sprayer)

BIOLOGICAL

Placebo

Placebo was supplied in intranasal sprayers containing 0.5 mL of sucrose-phosphate buffer

Trial Locations (16)

14069

Rochester Clinical Research Inc., Rochester

15241

Primary Physicians Research, Inc., Pittsburgh

29303

Spartanburg Medical Research, Spartanburg

36608

Coastal Clinic Research, Inc., Mobile

40004

Kentucky Pediatric Research Center, Bardstown

40509

Central Kentucky Research Associates, Inc., Lexington

63141

Sundance Clinical Research, St Louis

68134

Meridian Clinical Research, Omaha

76135

Benchmark Research Ft. Worth, Fort Worth

76904

Benchmark Research San Angelo, San Angelo

78705

Benchmark Research, Austin

89105

Clinical Research Center of Nevada, Henderson

94102

Benchmark Research, San Francisco

95816

Benchmark Research, Sacramento

92103-6204

California Research Foundation, San Diego

02886

Omega Medical Research, Warwick